Arete Wealth Advisors, LLC Amgen Inc Transaction History

Arete Wealth Advisors, LLC

$1.22 Billion
Q2 2024

A detailed history of Arete Wealth Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Arete Wealth Advisors, LLC holds 5,231 shares of AMGN stock, worth $1.65 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

5,231

Holding current value

$1.65 Million

% of portfolio

0.13%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $1.37 Million - $1.67 Million	5,231 New	5,231 $1.63 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $15,597 - $17,596	-61 Reduced 1.74%	3,446 $992,000
Q3 2023 Oct 30, 2023	SELL	$218.65 - $271.46 $384,168 - $476,955	-1,757 Reduced 33.38%	3,507 $942,000
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $517,890 - $612,395	-2,417 Reduced 31.47%	5,264 $1.17 Million
Q1 2023 May 01, 2023	SELL	$225.79 - $275.2 $233,015 - $284,006	-1,032 Reduced 11.84%	7,681 $1.86 Million
Q4 2022 Feb 06, 2023	BUY	$229.03 - $291.01 $341,254 - $433,604	1,490 Added 20.63%	8,713 $2.29 Million
Q3 2022 Nov 07, 2022	BUY	$224.46 - $253.15 $1.04 Million - $1.18 Million	4,655 Added 181.27%	7,223 $1.63 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $25,378 - $28,241	110 Added 4.48%	2,568 $626,000
Q1 2022 May 06, 2022	BUY	$219.27 - $242.57 $538,965 - $596,237	2,458 New	2,458 $594,000
Q4 2021 Feb 07, 2022	SELL	$198.88 - $227.6 $574,962 - $657,991	-2,891 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $3,396 - $3,979	-16 Reduced 0.55%	2,891 $615,000
Q2 2021 Aug 09, 2021	SELL	$233.58 - $259.14 $31,533 - $34,983	-135 Reduced 4.44%	2,907 $557,000
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $26,185 - $30,514	-118 Reduced 3.73%	3,042 $757,000
Q4 2020 Feb 08, 2021	SELL	$216.38 - $257.67 $488,586 - $581,818	-2,258 Reduced 41.68%	3,160 $724,000
Q3 2020 Nov 09, 2020	BUY	$234.65 - $260.95 $234 - $260	1 Added 0.02%	5,418 $1.33 Million
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $162,995 - $200,017	824 Added 17.94%	5,417 $1.28 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $28,611 - $37,946	157 Added 3.54%	4,593 $931,000
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $378 - $486	2 Added 0.05%	4,436 $1.07 Million
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $87,925 - $105,353	505 Added 12.85%	4,434 $858,000
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $2.97 Million - $3.48 Million	-17,792 Reduced 81.91%	3,929 $724,000
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $118,469 - $133,541	655 Added 3.11%	21,721 $4.13 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $2,854 - $3,332	-16 Reduced 0.08%	21,066 $4.1 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $557,908 - $628,967	-3,011 Reduced 12.5%	21,082 $4.37 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $2.99 Million - $3.36 Million	17,992 Added 294.9%	24,093 $4.45 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $169,260 - $197,802	-999 Reduced 14.07%	6,101 $1.04 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $68,697 - $76,756	-407 Reduced 5.42%	7,100 $1.24 Million
Q3 2017 Nov 15, 2017	BUY	$167.29 - $191.0 $1.26 Million - $1.43 Million	7,507	7,507 $1.4 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arete Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arete Wealth Advisors, LLC with notifications on news.

Account

Arete Wealth Advisors, LLC Amgen Inc Transaction History